| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 30 |
| 1 | METHOTREXATE | 27 |
| 2 | ADALIMUMAB | 19 |
| 3 | INFLIXIMAB | 18 |
| 4 | DICLOFENAC SODIUM | 17 |
| 5 | DICLOFENAC | 16 |
| 6 | PREDNISOLONE | 16 |
| 7 | PREDNISOLONE ORAL | 16 |
| 8 | PREDNISOLONE ORAL SOLUTION | 16 |
| 9 | NAPROXEN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 1 | 0.0012 |
| 1 | CANAKINUMAB | 12 | 0.0011 |
| 2 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 3 | BELATACEPT | 2 | 0.0004 |
| 4 | PATISIRAN | 1 | 0.0004 |
| 5 | VUTRISIRAN | 1 | 0.0003 |
| 6 | COLCHICINE | 8 | 0.0003 |
| 7 | ANAKINRA | 5 | 0.0003 |
| 8 | ADALIMUMAB-FKJP | 12 | 0.0003 |
| 9 | ADALIMUMAB-AATY | 12 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 39 |
| 1 | Corticosteroid [EPC] | 38 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 27 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 4 | Opioid Agonist [EPC] | 12 |
| 5 | Loop Diuretic [EPC] | 11 |
| 6 | Proteasome Inhibitor [EPC] | 10 |
| 7 | Thalidomide Analog [EPC] | 10 |
| 8 | Alkylating Drug [EPC] | 9 |
| 9 | Alkaloid [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 2 | Alkaloid [EPC] | 8 | 0.0003 |
| 3 | Interleukin-1 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 4 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 5 | Tetracycline-class Drug [EPC] | 8 | 0.0001 |
| 6 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Proteasome Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 8 | 0.0001 |